Cargando…
Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
BACKGROUND: Cochrane recently published a review of esketamine and other glutamate receptor modulators in depression. AIM: To address the limitations of the review, analyses of esketamine data were conducted to provide additional perspective to the reviewers’ interpretation of their findings. METHOD...
Autores principales: | Borentain, Stephane, Desai, Pooja, Fu, Dong-Jing, Nancy Chen, Li, Lane, Rosanne, Mathews, Maju, Canuso, Carla M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399093/ https://www.ncbi.nlm.nih.gov/pubmed/36218274 http://dx.doi.org/10.1177/02698811221123046 |
Ejemplares similares
-
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
por: Fu, Dong-Jing, et al.
Publicado: (2023) -
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
por: Borentain, Stephane, et al.
Publicado: (2021) -
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
por: Zheng, Wei, et al.
Publicado: (2021) -
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression
por: Morrens, Joachim, et al.
Publicado: (2022) -
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials
por: Diekamp, Bettina, et al.
Publicado: (2021)